{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:44:06Z","timestamp":1789548246003,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1344,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/mt.2012.258","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T08:22:45Z","timestamp":1355818965000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Minimizing the Inhibitory Effect of Neutralizing Antibody for Efficient Gene Expression in the Liver With Adeno-associated Virus 8 Vectors"],"prefix":"10.1016","volume":"21","author":[{"given":"Jun","family":"Mimuro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Ikemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Madoiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.258_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2013from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.258_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2001.03225.x","article-title":"Gene therapy for haemophilia","volume":"115","author":"Pasi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2012.258_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1046\/j.1538-7836.2003.00265.x","article-title":"Gene therapy for the hemophilias","volume":"1","author":"VandenDriessche","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"suppl. 4","key":"10.1038\/mt.2012.258_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2516.2004.00984.x","article-title":"Preclinical and clinical gene therapy for haemophilia","volume":"10","author":"Chuah","year":"2004","journal-title":"Haemophilia"},{"key":"10.1038\/mt.2012.258_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2004-825638","article-title":"Clinical gene transfer studies for hemophilia A","volume":"30","author":"Chuah","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1038\/mt.2012.258_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/gt.2008.71","article-title":"AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects","volume":"15","author":"Hasbrouck","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.258_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/156652311796150354","article-title":"Immune responses to AAV in clinical trials","volume":"11","author":"Mingozzi","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2012.258_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/73464","article-title":"Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector","volume":"24","author":"Kay","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2012.258_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ymthe.2006.05.004","article-title":"Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B","volume":"14","author":"Jiang","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.258_bib10","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2012.258_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.258_bib12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2002-02-0589","article-title":"Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques","volume":"100","author":"Nathwani","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mt.2012.258_bib13","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2012.258_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood-2006-03-010181","article-title":"Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates","volume":"109","author":"Nathwani","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2012.258_bib15","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.258_bib16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.258_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.thromres.2010.01.049","article-title":"Mutant macaque factor IX T262A: a tool for hemophilia B gene therapy studies in macaques","volume":"125","author":"Ishiwata","year":"2010","journal-title":"Thromb Res"},{"key":"10.1038\/mt.2012.258_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1038\/mt.2012.258_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.1840070527","article-title":"Conceptual review of the hepatic vascular bed","volume":"7","author":"Lautt","year":"1987","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.258_bib20","series-title":"Hepatology: A Textbook of Liver Disease","first-page":"3","article-title":"Anatomy and physilogy of the liver","author":"Saxena","year":"2003"},{"key":"10.1038\/mt.2012.258_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/asheducation-2007.1.466","article-title":"Update on progress and hurdles in novel genetic therapies for hemophilia","author":"High","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1038\/mt.2012.258_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-61779-370-7_6","article-title":"AAV-mediated liver-directed gene therapy","volume":"807","author":"Sands","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2012.258_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fmicb.2011.00204","article-title":"Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity","volume":"2","author":"Bartel","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1038\/mt.2012.258_bib24","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/mt.2010.175","article-title":"Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy","volume":"18","author":"Hurlbut","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.258_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/gt.2011.90","article-title":"Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia","volume":"19","author":"Li","year":"2012","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.258_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/mt.2011.73","article-title":"A barrel of monkeys: scAAV8 gene therapy for hemophilia in nonhuman primates","volume":"19","author":"Chandler","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.258_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.258_bib28","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/CVI.05107-11","article-title":"Adeno-associated virus antibody profiles in newborns, children, and adolescents","volume":"18","author":"Calcedo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mt.2012.258_bib29","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.258_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1152\/jappl.1975.38.5.786","article-title":"Cardiorespiratory effects of rapid saline infusion in normal man","volume":"38","author":"Muir","year":"1975","journal-title":"J Appl Physiol"},{"key":"10.1038\/mt.2012.258_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1038\/mt.2012.258_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1113\/jphysiol.1974.sp010482","article-title":"Capacitance effects and blood reservoir function in the splanchnic vascular bed during non-hypotensive haemorrhage and blood volume expansion in anaesthetized cats","volume":"237","author":"Greenway","year":"1974","journal-title":"J Physiol (Lond)"},{"key":"10.1038\/mt.2012.258_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1152\/ajplegacy.1976.231.2.292","article-title":"Hepatic venous compliance and role of liver as a blood reservoir","volume":"231","author":"Lautt","year":"1976","journal-title":"Am J Physiol"},{"key":"10.1038\/mt.2012.258_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1538-7933.2003.00572.x","article-title":"Specific detection of human coagulation factor IX in cynomolgus macaques","volume":"2","author":"Mimuro","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2012.258_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/JVI.74.4.1761-1766.2000","article-title":"Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure","volume":"74","author":"Moskalenko","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.258_bib36","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/nar\/gkh593","article-title":"Expression of the adenovirus E4 34k oncoprotein inhibits repair of double strand breaks in the cellular genome of a 293-based inducible cell line","volume":"32","author":"Mohammadi","year":"2004","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:12:34Z","timestamp":1777997554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616305925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1525001616305925"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.258","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimizing the Inhibitory Effect of Neutralizing Antibody for Efficient Gene Expression in the Liver With Adeno-associated Virus 8 Vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2012.258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}